(Q43176620)

15 November 2017

Short term testosterone replacement therapy improves libido and body composition (English)

1 reference

15 November 2017

1 reference

Edésio Seara de Andrade

series ordinal

1

1 reference

15 November 2017

Ruth Clapauch

series ordinal

2

1 reference

15 November 2017

Salo Buksman

series ordinal

3

1 reference

15 November 2017

language of work or name

1 reference

1 November 2009

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

15 November 2017

1 reference

15 November 2017

53

1 reference

15 November 2017

8

1 reference

15 November 2017

996-1004

1 reference

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

15 November 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Androgens and the ageing male

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Laboratory diagnosis of late-onset male hypogonadism andropause

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Aging Males' Symptoms scale in Japanese men attending a multiphasic health screening clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Considerations for the diagnosis and treatment of testosterone deficiency in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

The management of hypogonadism in aging male patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Double blind randomized placebo-controlled trial on the effects of testosterone supplementation in elderly men with moderate to low testosterone levels: design and baseline characteristics [ISRCTN23688581].

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Recent insights into androgen action on the anatomical and physiological substrate of penile erection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

The relationship between libido and testosterone levels in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

The effects of treating male hypogonadism on couples' sexual desire and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Prevalence of erectile dysfunction among middle-aged men in a metropolitan area in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Androgens, insulin resistance and vascular disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Insulin sensitivity during combined androgen blockade for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Testosterone replacement therapy and the risk of prostate cancer. Is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Lower urinary tract symptoms after hormone replacement therapy in Japanese patients with late-onset hypogonadism: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Andropause: Symptom Management for Prostate Cancer Patients Treated With Hormonal Ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

Testosterone therapy in the aging male

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800014

10.1590/S0004-27302009000800014

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference